← Leaderboards
Robert H Gilman
Johns Hopkins University
$35,342,766
Attributed
$41,235,293
Total exposure
28
Grants
18
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,961,606 · 29
By mechanism
R01$25,930,421 · 8
D43$8,312,095 · 4
U01$5,891,435 · 4
R21$2,717,643 · 7
T35$782,495 · 2
R56$571,071 · 1
Top collaborators
- Subhra Chakraborty6 shared
- Hector Hugo Garcia5 shared
- Sarah Odell Gimbel5 shared
- Richard A Oberhelman4 shared
- Paul Blair2 shared
- Natalie Mccarter Bowman2 shared
- Tony Y. Hu2 shared
- Laura-Isobel Mccall2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- William George Nelson$34,555,726
- Nancy E Davidson$32,860,580
- Marcia R Cruz Correa$7,817,319
- Linda J Van Eldik$37,023,709
- Martin G Pomper$38,517,075
Others in their field
Top investigators on “Peru”
- Lawrence Corey · Fred Hutchinson Cancer Center$205,096,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$45,710,868
- Fred M Gordin · Social And Scientific Systems, Inc.$44,160,542
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,087,946
- Robert M. Grant · J. David Gladstone Institutes$41,279,316
Research focus
PeruLaboratoriesProgramsCountryBaseGrantInfectionTrainingBoliviaCommunicable DiseasesDiagnosisEpidemiologyChagas DiseaseUniversitiesCommunitiesTuberculosisCostResourcesCollaborationsAreaDiagnosticResearch PersonnelGrowthCohort
Grant awards (137)
Lung Ultrasound and Artificial Intelligence Technology for the Diagnosis of TB in LMICs$620,640
R01 · FY2025 · HL · contact PI
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia$570,008
R01 · FY2025 · AI
Training in Infectious Diseases in Peru - Time for Implementation Research$290,320
D43 · FY2025 · TW
Infectious Diseases Training program in Bolivia: South-South-North Training with Peru and JHU$288,300
D43 · FY2025 · TW · contact PI
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia$120,406
R01 · FY2025 · AI
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia$698,064
R01 · FY2024 · AI
Lung Ultrasound and Artificial Intelligence Technology for the Diagnosis of TB in LMICs$675,306
R01 · FY2024 · HL · contact PI
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites$645,054
R01 · FY2024 · AI · contact PI
Maternally acquired immunity in protection against enterotoxigenic E. coli infections in infants$571,071
R56 · FY2024 · AI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$293,875
D43 · FY2024 · TW · contact PI
Training in Infectious Diseases in Peru - Time for Implementation Research$289,680
D43 · FY2024 · TW
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia$751,006
R01 · FY2023 · AI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$717,912
R01 · FY2023 · AI · contact PI
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites$651,979
R01 · FY2023 · AI · contact PI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$300,312
D43 · FY2023 · TW · contact PI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$293,857
D43 · FY2023 · TW · contact PI
Training in Infectious Diseases in Peru - Time for Implementation Research$290,321
D43 · FY2023 · TW
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$708,255
R01 · FY2022 · AI · contact PI
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites$650,548
R01 · FY2022 · AI · contact PI
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America$645,227
R01 · FY2022 · AI · contact PI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$293,827
D43 · FY2022 · TW · contact PI
Training in Infectious Diseases in Peru - Time for Implementation Research$290,320
D43 · FY2022 · TW
Small molecule biomarkers of cardiac Chagas disease progression$234,971
R21 · FY2022 · AI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$710,220
R01 · FY2021 · AI · contact PI
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites$663,204
R01 · FY2021 · AI · contact PI
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America$648,345
R01 · FY2021 · AI · contact PI
Training in Infectious Diseases in Peru - Time for Implementation Research$294,960
D43 · FY2021 · TW
Infectious Diseases Training program in Bolivia: South-South Training with Peru$294,608
D43 · FY2021 · TW · contact PI
Small molecule biomarkers of cardiac Chagas disease progression$223,523
R21 · FY2021 · AI
Improved Diagnostics Assays for Viable or Degenerating Neurocysticercosis$85,132
U19 · FY2021 · AI · contact PI
Using the Mycobacterium tuberculosis Genome to Predict Tuberculosis Pathology, Drug Resistance Acquisition and Identify Community Transmission Sites$722,155
R01 · FY2020 · AI · contact PI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$710,207
R01 · FY2020 · AI · contact PI
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America$652,766
R01 · FY2020 · AI · contact PI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$299,166
D43 · FY2020 · TW · contact PI
Investigating platelets in the innate immune response to tuberculosis$160,738
R21 · FY2020 · AI · contact PI
Improved Diagnostics Assays for Viable or Degenerating Neurocysticercosis$85,132
U19 · FY2020 · AI · contact PI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$1,056,841
R01 · FY2019 · AI · contact PI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$736,006
R01 · FY2019 · AI · contact PI
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America$658,567
R01 · FY2019 · AI · contact PI
Investigating platelets in the innate immune response to tuberculosis$225,758
R21 · FY2019 · AI · contact PI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$213,353
D43 · FY2019 · TW · contact PI
Improved Diagnostics Assays for Viable or Degenerating Neurocysticercosis$81,820
U19 · FY2019 · AI · contact PI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$1,066,175
R01 · FY2018 · AI · contact PI
Novel nanoparticular diagnostics for cerebral toxoplasmosis and Chagas in HIV patients living in Latin America$729,479
R01 · FY2018 · AI · contact PI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$575,258
R01 · FY2018 · AI · contact PI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$213,600
D43 · FY2018 · TW · contact PI
Improved Diagnostics Assays for Viable or Degenerating Neurocysticercosis$84,439
U19 · FY2018 · AI · contact PI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$1,075,705
R01 · FY2017 · AI · contact PI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$587,445
R01 · FY2017 · AI · contact PI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$214,079
D43 · FY2017 · TW · contact PI
Improved Diagnostics Assays for Viable or Degenerating Neurocysticercosis$85,179
U19 · FY2017 · AI · contact PI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$641,504
R01 · FY2016 · AI · contact PI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$599,662
R01 · FY2016 · AI · contact PI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$384,741
R01 · FY2016 · AI · contact PI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$269,895
D43 · FY2016 · TW · contact PI
Launching a salt substitute to reduce blood pressure at the population level-Peru$266,224
U01 · FY2016 · HL · contact PI
Oxfendazole as a Broad Spectrum Deworming Medicine in Humans: Phase II Efficacy Study in Geohelminths$233,227
R34 · FY2016 · AI · contact PI
Natural infection of norovirus and sapovirus in a birth cohort in a Peruvian periurban community$731,587
R01 · FY2015 · AI · contact PI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$611,534
R01 · FY2015 · AI · contact PI
Launching a salt substitute to reduce blood pressure at the population level-Peru$462,897
U01 · FY2015 · HL · contact PI
Infectious Diseases Training program in Bolivia: South-South Training with Peru$222,659
D43 · FY2015 · TW · contact PI
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia$672,642
R01 · FY2014 · AI · contact PI
Early Detection of Congenital Chagas Disease$571,175
R01 · FY2014 · AI · contact PI
Launching a salt substitute to reduce blood pressure at the population level-Peru$471,727
U01 · FY2014 · HL · contact PI
Early Detection of Congenital Chagas Disease$537,760
R01 · FY2013 · AI · contact PI
Launching a salt substitute to reduce blood pressure at the population level-Peru$468,095
U01 · FY2013 · HL · contact PI
Family Cluster Analysis of Norovirus Variants by Multiple-region Sequence Typing$166,104
R21 · FY2013 · AI · contact PI
Cough - A Rapid Indicator of Response to Therapy in Pulmonary Tuberculosis$160,972
R21 · FY2013 · AI · contact PI
Macrophage polarization and glutathione levels in the TB-helminth co-infection$154,047
R21 · FY2013 · AI · contact PI
Early Detection of Congenital Chagas Disease$561,364
R01 · FY2012 · AI · contact PI
Launching a salt substitute to reduce blood pressure at the population level-Peru$320,029
U01 · FY2012 · HL · contact PI
Cough - A Rapid Indicator of Response to Therapy in Pulmonary Tuberculosis$226,770
R21 · FY2012 · AI · contact PI
Macrophage polarization and glutathione levels in the TB-helminth co-infection$224,695
R21 · FY2012 · AI · contact PI
Family Cluster Analysis of Norovirus Variants by Multiple-region Sequence Typing$220,890
R21 · FY2012 · AI · contact PI
Global Disease Research Training Program in Peru$138,982
D43 · FY2012 · TW · contact PI
Early Detection of Congenital Chagas Disease$575,328
R01 · FY2011 · AI · contact PI
Global Disease Research Training Program in Peru$138,982
D43 · FY2011 · TW · contact PI
Early Detection of Congenital Chagas Disease$651,023
R01 · FY2010 · AI · contact PI
Novel techniques for the detection of Pediatric TB in Ethiopia$444,853
R01 · FY2010 · HD · contact PI
Global Disease Research Training Program in Peru$138,982
D43 · FY2010 · TW · contact PI
Johns Hopkins short term training grant in Infectious and Tropical Diseases in Pe$63,643
T35 · FY2010 · AI · contact PI
Novel techniques for the detection of Pediatric TB in Ethiopia$449,470
R01 · FY2009 · HD · contact PI
Global Disease Research Training Program in Peru$138,982
D43 · FY2009 · TW · contact PI
Short term training: Infectious Diseases and Tropical Diseases in Peru$63,303
T35 · FY2009 · AI · contact PI
Novel techniques for the detection of Pediatric TB in Ethiopia$451,000
R01 · FY2008 · HD · contact PI
Screening and Risk Factors for Cogenital Chagas Disease in Bolivia$158,933
R21 · FY2008 · AI · contact PI
Global Disease Research Training Program in Peru$150,000
D43 · FY2008 · TW · contact PI
Infectious Diseases Training Program in Peru$141,717
D43 · FY2008 · TW · contact PI
Short term training: Infectious Diseases & Tropical Diseases in Peru$67,970
T35 · FY2008 · AI · contact PI
Screening and Risk Factors for Cogenital Chagas Disease in Bolivia$212,522
R21 · FY2007 · AI · contact PI
Infectious Diseases Training Program in Peru$181,945
D43 · FY2007 · TW · contact PI
Infectious Diseases Training Program in Peru$139,748
D43 · FY2007 · TW · contact PI
Infectious Diseases Training Program in Peru$96,840
D43 · FY2007 · TW · contact PI
Short term training: Infectious Diseases & Tropical Diseases in Peru$67,769
T35 · FY2007 · AI · contact PI
Infectious Diseases Training Program in Peru$50,000
D43 · FY2007 · TW · contact PI
Infectious Diseases Training Program in Peru$10,000
D43 · FY2007 · TW · contact PI
Infectious Diseases Training Program in Peru$196,633
D43 · FY2006 · TW · contact PI
Infectious Diseases Training Program in Peru$142,493
D43 · FY2006 · TW · contact PI
Johns Hopkins short term training grant in Infectious and Tropical Diseases in Pe$62,538
T35 · FY2006 · AI · contact PI
Infectious Diseases Training Program in Peru$159,255
D43 · FY2005 · TW
Transmission Dynamics of Cryptosporidium sp$151,088
R21 · FY2005 · AI
Infectious Diseases Training Program in Peru$149,965
D43 · FY2005 · TW
INTERGRATED CONTROL OF TAENIA SOLIUM CYSTICERCOSIS$890,159
U01 · FY2004 · AI
Transmission Dynamics of Cryptosporidium sp$196,632
R21 · FY2004 · AI
Infectious Diseases Training Program in Peru$149,042
D43 · FY2004 · TW
ACTIONS FOR BUILDING CAPACITY$100,000
D43 · FY2004 · TW
TUTORIAL IN TROPICAL HEALTH AT JHU/PERU OVERSEAS SITES$99,948
T35 · FY2004 · AI
Infectious Diseases Training Program in Peru$81,680
D43 · FY2004 · TW
Significance of Edema Around Calcified Brain Cysticerci$32,847
R03 · FY2004 · TW
INTERGRATED CONTROL OF TAENIA SOLIUM CYSTICERCOSIS$28,750
U01 · FY2004 · AI
INTERGRATED CONTROL OF TAENIA SOLIUM CYSTICERCOSIS$955,217
U01 · FY2003 · AI
Infectious Diseases Training Program in Peru$149,992
D43 · FY2003 · TW
ACTIONS FOR BUILDING CAPACITY$100,000
D43 · FY2003 · TW
TUTORIAL IN TROPICAL HEALTH AT JHU/PERU OVERSEAS SITES$92,327
T35 · FY2003 · AI
Significance of Edema Around Calcified Brain Cysticerci$34,132
R03 · FY2003 · TW
INTERGRATED CONTROL OF TAENIA SOLIUM CYSTICERCOSIS$613,273
U01 · FY2002 · AI
PERU EMERGING INFECTIONS TRAINING AND RESEARCH$134,670
D43 · FY2002 · TW
ACTIONS FOR BUILDING CAPACITY$100,000
D43 · FY2002 · TW
TUTORIAL IN TROPICAL HEALTH AT JHU/PERU OVERSEAS SITES$95,234
T35 · FY2002 · AI
PERU EMERGING INFECTIONS TRAINING AND RESEARCH$75,300
D43 · FY2002 · TW
Significance of Edema Around Calcified Brain Cysticerci$34,538
R03 · FY2002 · TW
Vaccine development for porcine cysticercosis: oncosphere antigens$0
U01 · FY2002 · AI
FIELD APPLICABLE SEROLOGIC DIAGNOSIS TESTS: CYSTICEROSIS &TAENIASIS$0
U01 · FY2002 · AI
INTERGRATED CONTROL OF TAENIA SOLIUM CYSTICERCOSIS$617,406
U01 · FY2001 · AI
PERU EMERGING INFECTIONS TRAINING AND RESEARCH$298,096
D43 · FY2001 · TW
ACTIONS FOR BUILDING CAPACITY$119,958
D43 · FY2001 · TW
TUTORIAL IN TROPICAL HEALTH AT JHU/PERU OVERSEAS SITES$87,059
T35 · FY2001 · AI
FIELD APPLICABLE SEROLOGIC DIAGNOSIS TESTS: CYSTICEROSIS &TAENIASIS$0
U01 · FY2001 · AI
Vaccine development for porcine cysticercosis: oncosphere antigens$0
U01 · FY2001 · AI
INTERGRATED CONTROL OF TAENIA SOLIUM CYSTICERCOSIS$621,508
U01 · FY2000 · AI
PERU EMERGING INFECTIONS TRAINING AND RESEARCH$193,801
D43 · FY2000 · TW
ACTIONS FOR BUILDING CAPACITY$100,000
D43 · FY2000 · TW
FIELD APPLICABLE SEROLOGIC DIAGNOSIS TESTS: CYSTICEROSIS &TAENIASIS$88,075
U01 · FY2000 · AI
Vaccine development for porcine cysticercosis: oncosphere antigens$88,075
U01 · FY2000 · AI
TUTORIAL IN TROPICAL HEALTH AT JHU/PERU OVERSEAS SITES$82,704
T35 · FY2000 · AI
PERU EMERGING INFECTIONS TRAINING AND RESEARCH$71,794
D43 · FY2000 · TW
PERU EMERGING INFECTIONS TRAINING AND RESEARCH$10,106
D43 · FY2000 · TW